{"pub": "investingcom", "url": "https://au.investing.com/news/stock-market-news/briefcynata-therapeutics-says-fujifilm-granted-license-to-commercialise-cos-product-1957773", "downloaded_at": "2019-09-17 11:25:43.085316+00:00", "title": "BRIEF-Cynata Therapeutics Says Fujifilm Granted License To Commercialise Co's Product", "language": "en", "text": "BRIEF-Cynata Therapeutics Says Fujifilm Granted License To Commercialise Co's Product\n\nStock Markets 25 minutes ago (Sep 17, 2019 21:00)\n\n\u00a9 Reuters. BRIEF-Cynata Therapeutics Says Fujifilm Granted License To Commercialise Co's Product Sept 17 (Reuters) - Cynata Therapeutics Ltd : * CYNATA THERAPEUTICS - FUJIFILM GRANTED EXCLUSIVE, WORLDWIDE LICENSE TO DEVELOP & COMMERCIALISE CO'S LEAD MESENCHYMAL STEM CELL PRODUCT, CYP-001 * CYNATA THERAPEUTICS - CYNATA WILL RECEIVE US$3 MILLION CASH FROM FUJIFILM AS AN UPFRONT FEE UNDER TRANSACTION * CYNATA THERAPEUTICS- CO WILL POTENTIALLY RECEIVE ADDITIONAL PAYMENTS FROM FUJIFILM OF UP TO US$43M BASED ON ATTAINMENT OF CERTAIN MILESTONES * CYNATA THERAPEUTICS - CO WILL RECEIVE A 10% ROYALTY ON ALL FUTURE PRODUCT SALES IF LICENSED PRODUCT IS SUCCESSFULLY COMMERCIALISED IN ANY COUNTRY\n\nBRIEF-Cynata Therapeutics Says Fujifilm Granted License To Commercialise Co's Product", "description": "BRIEF-Cynata Therapeutics Says Fujifilm Granted License To Commercialise Co's Product", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXMPEB230DM_L.jpg", "published_at": "2019-09-17"}